The discovery of the first oral anticoagulant, warfarin, was a milestone in anticoagulation. Warfarin's well-known limitations, however, have led to the recent development of more effective anticoagulants. The rapidly growing list of these drugs, however, presents a challenge to endoscopists who must treat patients on these sundry medications. This review is intended to summarize the pharmacological highlights of new anticoagulants, with particular attention to suggested "best-practice" recommendations for the withholding of these drugs before endoscopic procedures.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1038/ajg.2013.228 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!